Received May 28, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | — | — |
A 17 Year Old Received Heplisav-B; Initial report received on 19-May-2026. A nurse reported that a 17-year-old female patient (race and ethnicity unknown) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history or concomitant medications were reported. On 12-May-2026, the patient received an unknown dose of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC #, site, and route not reported). The patient was 17 years old when she received HEPLISAV-B. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.